These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 15893901

  • 1. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
    Baltch AL, Bopp LH, Smith RP, Ritz WJ, Carlyn CJ, Michelsen PB.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
    Madhavan P, Jamal F, Chong PP, Ng KP.
    Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
    [Abstract] [Full Text] [Related]

  • 8. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT, Cañadas J, García-Martos P, Marín P, García-Tapia A, Rodríguez J.
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [Abstract] [Full Text] [Related]

  • 9. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study.
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M, Scaltrito MM, Morace G, GISIA-2 Group.
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Burn AK, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, McCarthy DI, Rinaldi MG, Redding SW.
    J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
    [Abstract] [Full Text] [Related]

  • 12. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T, Farrokhshad K, Brummer E, Stevens DA.
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [Abstract] [Full Text] [Related]

  • 13. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M, Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [Abstract] [Full Text] [Related]

  • 14. Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.
    Baltch AL, Lawrence D, Ritz WJ, Andersen N, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.
    Chemotherapy; 2012 Jun; 58(2):146-51. PubMed ID: 22584412
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 16. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, Newell VA.
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
    Wang M, Friedman H, Djeu JY.
    J Immunol; 1989 Jul 15; 143(2):671-7. PubMed ID: 2661688
    [Abstract] [Full Text] [Related]

  • 18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec 15; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 19. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC, Chen YH, Chen YC, Lu PL.
    Kaohsiung J Med Sci; 2012 Jun 15; 28(6):306-15. PubMed ID: 22632885
    [Abstract] [Full Text] [Related]

  • 20. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Vora S, Purimetla N, Brummer E, Stevens DA.
    Antimicrob Agents Chemother; 1998 Apr 15; 42(4):907-10. PubMed ID: 9559806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.